69 related articles for article (PubMed ID: 4000099)
21. [In vitro drug-sensitivity test using human tumor clonogenic assay in lung cancer patients].
Ohnoshi T; Hiraki S
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1582-7. PubMed ID: 3927847
[TBL] [Abstract][Full Text] [Related]
22. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
Reddel RR; Murphy LC; Hall RE; Sutherland RL
Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
[TBL] [Abstract][Full Text] [Related]
23. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
[TBL] [Abstract][Full Text] [Related]
24. [Experimental and clinical studies on chemosensitivity tests of anticancer agents by human tumor clonogenic assay].
Hirabayashi N
Nihon Geka Gakkai Zasshi; 1986 Aug; 87(8):834-45. PubMed ID: 3092023
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D, tamoxifen and beta-estradiol modulate breast cancer cell growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium.
Paduch R; Kandefer-Szerszeń M
Cell Biol Toxicol; 2005; 21(5-6):247-56. PubMed ID: 16323060
[TBL] [Abstract][Full Text] [Related]
26. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
27. Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells.
McClay EF; Albright KD; Jones JA; Christen RD; Howell SB
Cancer Res; 1993 Apr; 53(7):1571-6. PubMed ID: 8453625
[TBL] [Abstract][Full Text] [Related]
28. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
Chang SB; Miron P; Miron A; Iglehart JD
J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
[TBL] [Abstract][Full Text] [Related]
29. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
30. [Sensitivity testing of anticancer drugs using the human tumor clonogenic assay].
Hiraki S; Ohnoshi T; Kishimoto N; Mori K; Nishii K; Yonei T; Yamashita H; Kimura I
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1208-13. PubMed ID: 3729443
[TBL] [Abstract][Full Text] [Related]
31. Involvement of the polyamine pathway in antiestrogen-induced growth inhibition of human breast cancer.
Cohen FJ; Manni A; Glikman P; Bartholomew M; Demers L
Cancer Res; 1988 Dec; 48(23):6819-25. PubMed ID: 3180091
[TBL] [Abstract][Full Text] [Related]
32. Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay.
Inomata M; Kaneko A
Jpn J Cancer Res; 1987 Aug; 78(8):858-68. PubMed ID: 3115934
[TBL] [Abstract][Full Text] [Related]
33. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
Chen J; Hui E; Ip T; Thompson LU
Clin Cancer Res; 2004 Nov; 10(22):7703-11. PubMed ID: 15570004
[TBL] [Abstract][Full Text] [Related]
34. Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines.
Vendrell JA; Bieche I; Desmetz C; Badia E; Tozlu S; Nguyen C; Nicolas JC; Lidereau R; Cohen PA
Endocr Relat Cancer; 2005 Mar; 12(1):75-92. PubMed ID: 15788640
[TBL] [Abstract][Full Text] [Related]
35. [In vitro chemosensitivity testing with the human tumor stem cell assay (HTSCA) in breast cancer].
Dittrich C
Wien Klin Wochenschr; 1984 Jun; 96(13):508-16. PubMed ID: 6475079
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of human tumor clonogenic and nude mouse-isotope assays in anticancer-agent sensitivity tests].
Hirabayashi N; Nosoh Y; Nishiyama M; Yamaguchi M; Yoshinaka K; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1808-12. PubMed ID: 3929691
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
Coezy E; Borgna JL; Rochefort H
Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of steroid hormone sensitivity of human breast cancer cells in culture (MCF-7) by a colony formation method].
Nomura Y; Matsui K; Tashiro H; Hamada Y; Saeki K
Gan To Kagaku Ryoho; 1983 May; 10(5):1335-41. PubMed ID: 6870300
[TBL] [Abstract][Full Text] [Related]
39. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
40. [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].
Kimura I; Ohnoshi T; Hiraki S; Miyamoto H
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):830-6. PubMed ID: 3032107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]